To determine the effects of the 7aaRGD peptide on tumor-infiltrating myeloid cells in vivo, we compared the transcriptomic profiles of FACS-sorted glioma-associated CD11b+ cells from all experimental groups. Here, ITGAM is linked to central nervous system cancer.